Reactive carbonyl compounds related uremic toxicity ("carbonyl stress")

Kidney International, Supplement

Volumn 59, Issue 78, 2001, Pages

  Miyata, T ^a   Sugiyama, S ^a   Saito, A ^a   Kurokawa, K ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Advanced lipoxidation end products; Carbohydrates; Lipids; Nonenzymatic biochemistry; Renal failure; Uremia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBOHYDRATE; CARBONYL DERIVATIVE; LIPID; UREMIC TOXIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; PROTEIN; VASCULOTROPIN; VASCULOTROPIN A;

BIOCHEMISTRY; CONFERENCE PAPER; GLYCATION; HUMAN; KIDNEY FAILURE; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; STRESS; UREMIA; AMYLOIDOSIS; ARTERIOSCLEROSIS; CHRONIC KIDNEY FAILURE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEUM; RENAL REPLACEMENT THERAPY; REVIEW;

AMYLOIDOSIS; ARTERIOSCLEROSIS; ENDOTHELIAL GROWTH FACTORS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; LYMPHOKINES; MAILLARD REACTION; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PERITONEUM; PROTEINS; RENAL DIALYSIS; UREMIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035130251     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.59780025.x     Document Type: Conference Paper

References (66)

1. The Maillard reaction in aging diabetes and nutrition
2. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
3. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus
4. Plasma level of pentosidine, an advanced glycation end product, in diabetic patients
5. Accumulation of Maillard reaction products in skin collagen in diabetes and aging
6. Structure elucidation of a senescence crosslink from human extracellular matrix
7. ∈-carboxymethyllysine as a degradation product of fructoselysine in glycated protein
8. Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin forming amyloid fibrils in patients with dialysis-related amyloidosis
9. ∈-(carboxymethyl) lysine, is a product of lipid peroxidation and glycoxidation reactions
10. Accumulation of albumin: Linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine
11. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia?
12. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: Evidence for increased oxidative stress in uremia
13. ∈-(carboxymethyl) lysine in aortas of hemodialysis patients
14. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehyde
15. Alterations in non-enzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
16. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction
17. Advanced glycation and development of diabetic complications: Unifying the involvement of glucose, methylglyoxal and oxidative stress
18. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of protein by glucose
19. Role of sugar fragmentation in the Maillard reaction, in Amino-Carbonyl Reaction
20. ∈-(carboxymethyl) lysine by reaction between lysine and products of autoxidation of ascorbate
21. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanol, and acrolein: A mechanism for the generation of highly reactive α-hydroxy and α, β-unsaturated aldehydes by phagocytes at sites of inflammation
22. Elevated serum levels of 3 deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients
23. Carbonyl stress in uremia: Accumulation of carbonyls accelerate the formation of pentosidine, an advanced glycation end product
24. Increase in three α, β-dicarbonyl compound levels in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction
25. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure
26. Erythrocyte redox state in uremic anemia: Effects of hemodialysis and relevance of glutathione metabolism
27. Quantitative and qualitative changes of serum albumin in CAPD patients
28. Advanced oxidation protein products as a novel marker of oxidative stress in uremia
29. Protein oxidation in hemodialysis and kidney transplantation
30. Effects of glycerol-induced acute renal failure on tissue glutathione and glutathione-dependent enzymes in the rat
31. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia
32. Detection of oxidant in uremic plasma by electron spin resonance spectroscopy
33. Metal catalyzed oxidation of proteins: Physiological consequences
34. Metabolism of glucose in human erythrocytes by the polyol pathway
35. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress."
36. β2-Microglobulin in renal disease
37. Histological prevalence of β2-microglobulin amyloidosis in haemodialysis: A prospective post-mortem study
38. β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis
39. Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis
40. The receptor for advanced glycation end products mediates the interaction of AGE-β2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: Implication for the pathogenesis of dialysis-related amyloidosis
41. Advanced glycosylation end products in patients with diabetic nephropathy
42. 2-Isopropylidenehydrazono-4-oxo-thiazolidin-5ylacetanilide (OPB-9195) inhibits the neointima proliferation of rat carotid artery following balloon injury: Role of glycoxidation and lipoxidation reactions in vascular tissue damage
43. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acid
44. The peritoneal membrane in chronic peritoneal dialysis
45. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes
46. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis
47. Immunohistochemical detection of advanced glycation end-products in the peritoneum and its possible pathophysiological role in CAPD
48. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis
49. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis
50. The biology of vascular endothelial growth factor
51. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin 1
52. Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products
53. β2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis
54. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted with devitalized bone particles
55. Advanced glycation end products stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells
56. Increased aggregation of human platelets produced by advanced glycation end products in vitro
57. The working party on dialysis amyloidosis: Effect of dialysis membrane and patient's age on signs of dialysis related amyloidosis
58. Regulation of parathyroid hormone synthesis in chronic renal failure in rats
59. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins
60. Effect of glyoxylate on the function of the calcitriol receptor and vitamin D metabolism
61. Covalent chemical events in immune induction: Fundamental and therapeutic aspects
62. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
63. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
64. C-src
65. 4-Hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition
66. 4-hydroxynonenal induces Fas-independent redox-related activation of caspase-3